Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest biotechnology Stories

2014-04-01 08:30:20

Safety, Efficacy, Patient Satisfaction Drive StemGenex' Efforts toward Best-in-Class Stem Cell Treatment LA JOLLA, Calif., April 1, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today reinforced their commitment to attaining the highest treatment standards in the U.S. StemGenex believes by focusing on three key areas of treatment, patients will continue...

Japanese Scientist Falsified Claims On Groundbreaking Stem Cell Research
2014-04-01 08:43:26

Lawrence LeBlond for redOrbit.com - Your Universe Online Less than three months after a rising Japanese scientist made claims of a significant stem cell breakthrough, new evidence has come forward that confirms the findings of the groundbreaking study were falsified. Haruko Obokata, the lead author of a study published in the journal Nature in January, claimed that stem cells could be created by dipping blood cells into acid, potentially leading to hope in growing Stap...

2014-03-31 23:37:07

Top Tier Panelists from Onyx Pharmaceuticals, BioMarin Pharmaceutical, San Francisco State University, and Clinovo Share Experience on How to Conduct Successful Outsourcing Strategies Sunnyvale, CA (PRWEB) March 31, 2014 Outsourcing experts from Onyx Pharmaceuticals, San Francisco State University (SFSU), BioMarin Pharmaceutical, and Clinovo discussed the topic 'Manage In-house and Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management' at the...

2014-03-31 23:32:42

A new white paper from METTLER TOLEDO explores how inline monitoring techniques and simplified spectroscopy calibration can help maximize yield, batch-to-batch reproducibility, and economics of bioproducts as demand for them continues to increase. (PRWEB) March 31, 2014 METTLER TOLEDO is pleased to present a new installment in its white paper series on in situ spectroscopy applications. The paper, entitled “Understand and Control Bioprocesses: In Situ Analysis for Fermentation...

2014-03-31 23:32:32

Nominations Deadline: June 27, 2014; Open to all. Awards Ceremony: In conjunction with BioProcess International Conference & Exhibition, October 22, 2014, Boston, MA. New York, NY (PRWEB) March 31, 2014 BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces the 2014 BioProcess International Awards Dinner and Ceremony will take place...

2014-03-31 20:22:11

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fl4bmp/global_cell) has announced the addition of the "Global Cell Therapy Market & Pipeline Insight" [http://www.researchandmarkets.com/research/fl4bmp/global_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Research in cell therapy is transforming the future of medicine. As the life of a human being begins as...

2014-03-31 09:52:21

New insight has been gained into treating an inherited disorder that creates serious neurological and behavioral disabilities in children and usually leads to death in the teen years. In a recent study into the effects of human umbilical cord blood mononuclear cells (hUCB MNCs) when they are injected to counter the symptoms and progression of Sanfilippo syndrome type III B (MPS III B), researchers found that repeated injections into laboratory mice modeled with the disorder had clear...

2014-03-31 08:30:19

DALLAS, March 31, 2014 /PRNewswire/ -- According to a new market research report "Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Instruments, Reagents & Services - Global Forecast to 2018", published by MarketsandMarkets, The market was valued at $10,223.0 Million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018. Browse 138...

2014-03-31 08:29:19

SANTA MONICA, Calif., March 31, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for...

2014-03-31 08:28:28

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model BOSTON, March 31, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas, NV. It provides compelling insights that highlight the value of these multi-year, highly integrated...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »